Trial Profile
A phase I trial of GM.CD40L in cancer patients with stage IV disease
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Jun 2015
Price :
$35
*
At a glance
- Drugs CD40L GVAX (Primary)
- Indications Cancer
- Focus Adverse reactions
- 18 Jun 2015 New trial record